Researchers from Louisiana State University’s Health Science Center and Seattle Children’s Hospital were given a five-year federal grant by the National Institutes of Health (NIH) to study whether muscle power training exercises can improve the walking abilities of children with cerebral palsy (CP).
Is this exciting? It really is. Anything that can advance the ball for people with cerebral palsy is wildly exciting.
Approximately 574,000 bottles of Infants’ Tylenol Oral Suspension, are being recalled.
The recall affects the grape flavor, 1oz. bottles of Tylenol Oral Suspension, and has been made as a precaution after receiving a few complaints from consumers who reported difficulty using the Infants’ Tylenol SimpleMeasure dosing system. SimpleMeasure includes a dosing syringe, which a parent or caregiver inserts into a protective cover, or “flow restrictor,” at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe.
No adverse events have been reported, and the risk of a serious adverse medical event is remote.
The FDA is advising that an additional concentration of liquid acetaminophen marketed for “infants” is now available. The new concentration, 160 mg/5 ml, will affect the amount of liquid given to an infant and should be especially noted by consumers who are used to using the 80 mg /0.8 mL or 80 mg/mL concentrations of liquid acetaminophen.
The Over-the-Counter (OTC) Liquid acetaminophen is used to temporarily reduce fever and relieve minor aches and pains due to the common cold, flu, headache, minor sore throat, and toothache.
Acetaminophen is marketed under brand names such as:
Drug Recall Lawyer Blog